Experimental treatment of stroke in spontaneously hypertensive rats by CD34+ and CD34- cord blood cells
Human umbilical cord blood as a source of stem cells has recently been reported in experimental treatment of cerebral disorders. However, little is known about the nature of cells and cellular mechanisms leading to neurofunctional improvement. Here we investigated the potential of separated CD34+ ve...
Main Authors: | Egger, Dietmar, Buhrle, Christian, Gunther, Albrecht, Reich, Doreen, Geiger, Kathrin, Kowalski, Ina, Boltze, Johannes, Kamprad, Manja, Emmrich, Frank |
---|---|
Format: | Article |
Language: | deu |
Published: |
German Medical Science GMS Publishing House
2005-11-01
|
Series: | GMS German Medical Science |
Subjects: | |
Online Access: | http://www.egms.de/en/gms/2005-3/000027.shtml |
Similar Items
-
Neuronal hypoxia <it>in vitro</it>: Investigation of therapeutic principles of HUCB-MNC and CD133<sup>+ </sup>stem cells
by: Emmrich Frank, et al.
Published: (2008-09-01) -
Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia <it>in vitro</it>
by: Emmrich Frank, et al.
Published: (2008-02-01) -
Viability and intracellular nitric oxide generation in the umbilical cord blood CD34+CD133– and CD34+CD133+ cell populations exposed to local anaesthetics
by: Karolina I. Kulińska, et al.
Published: (2021-01-01) -
CD34+ stem cells from umbilical cord blood
by: Carlo Pafumi, et al.
Published: (2011-10-01) -
Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
by: Fritzenwanger M, et al.
Published: (2009-03-01)